341 related articles for article (PubMed ID: 23804447)
21. Anti-renal fibrosis effect of asperulosidic acid via TGF-β1/smad2/smad3 and NF-κB signaling pathways in a rat model of unilateral ureteral obstruction.
Xianyuan L; Wei Z; Yaqian D; Dan Z; Xueli T; Zhanglu D; Guanyi L; Lan T; Menghua L
Phytomedicine; 2019 Feb; 53():274-285. PubMed ID: 30668407
[TBL] [Abstract][Full Text] [Related]
22. Iron chelation by deferoxamine prevents renal interstitial fibrosis in mice with unilateral ureteral obstruction.
Ikeda Y; Ozono I; Tajima S; Imao M; Horinouchi Y; Izawa-Ishizawa Y; Kihira Y; Miyamoto L; Ishizawa K; Tsuchiya K; Tamaki T
PLoS One; 2014; 9(2):e89355. PubMed ID: 24586712
[TBL] [Abstract][Full Text] [Related]
23. Cysteine-rich protein 61 plays a proinflammatory role in obstructive kidney fibrosis.
Lai CF; Chen YM; Chiang WC; Lin SL; Kuo ML; Tsai TJ
PLoS One; 2013; 8(2):e56481. PubMed ID: 23457573
[TBL] [Abstract][Full Text] [Related]
24. In vivo silencing of amphiregulin by a novel effective Self-Assembled-Micelle inhibitory RNA ameliorates renal fibrosis via inhibition of EGFR signals.
Son SS; Hwang S; Park JH; Ko Y; Yun SI; Lee JH; Son B; Kim TR; Park HO; Lee EY
Sci Rep; 2021 Jan; 11(1):2191. PubMed ID: 33500443
[TBL] [Abstract][Full Text] [Related]
25. Pirfenidone suppresses MAPK signalling pathway to reverse epithelial-mesenchymal transition and renal fibrosis.
Li Z; Liu X; Wang B; Nie Y; Wen J; Wang Q; Gu C
Nephrology (Carlton); 2017 Aug; 22(8):589-597. PubMed ID: 27245114
[TBL] [Abstract][Full Text] [Related]
26. IN-1130, a novel transforming growth factor-beta type I receptor kinase (ALK5) inhibitor, suppresses renal fibrosis in obstructive nephropathy.
Moon JA; Kim HT; Cho IS; Sheen YY; Kim DK
Kidney Int; 2006 Oct; 70(7):1234-43. PubMed ID: 16929250
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of spleen tyrosine kinase (syk) suppresses renal fibrosis through anti-inflammatory effects and down regulation of the MAPK-p38 pathway.
Chen KH; Hsu HH; Yang HY; Tian YC; Ko YC; Yang CW; Hung CC
Int J Biochem Cell Biol; 2016 May; 74():135-44. PubMed ID: 26948651
[TBL] [Abstract][Full Text] [Related]
28. Overexpression of the short endoglin isoform reduces renal fibrosis and inflammation after unilateral ureteral obstruction.
Muñoz-Félix JM; Pérez-Roque L; Núñez-Gómez E; Oujo B; Arévalo M; Ruiz-Remolina L; Cuesta C; Langa C; Pérez-Barriocanal F; Bernabeu C; Lopez-Novoa JM
Biochim Biophys Acta; 2016 Sep; 1862(9):1801-14. PubMed ID: 27321931
[TBL] [Abstract][Full Text] [Related]
29. Endogenous relaxin is a naturally occurring modulator of experimental renal tubulointerstitial fibrosis.
Hewitson TD; Mookerjee I; Masterson R; Zhao C; Tregear GW; Becker GJ; Samuel CS
Endocrinology; 2007 Feb; 148(2):660-9. PubMed ID: 17095590
[TBL] [Abstract][Full Text] [Related]
30. Hydrogen Rich Water Attenuates Renal Injury and Fibrosis by Regulation Transforming Growth Factor-β Induced Sirt1.
Xing Z; Pan W; Zhang J; Xu X; Zhang X; He X; Fan M
Biol Pharm Bull; 2017; 40(5):610-615. PubMed ID: 28458345
[TBL] [Abstract][Full Text] [Related]
31. Upregulation of KLF14 expression attenuates kidney fibrosis by inducing PPARα-mediated fatty acid oxidation.
Chen L; Sha ML; Chen FT; Jiang CY; Li D; Xu CL; Pan DS; Xu ZJ; Tang QL; Xia SJ; Sun LH; Fan GJ; Shao Y
Free Radic Biol Med; 2023 Feb; 195():132-144. PubMed ID: 36584797
[TBL] [Abstract][Full Text] [Related]
32. Inhibitory effects of fasudil on renal interstitial fibrosis induced by unilateral ureteral obstruction.
Baba I; Egi Y; Utsumi H; Kakimoto T; Suzuki K
Mol Med Rep; 2015 Dec; 12(6):8010-20. PubMed ID: 26498136
[TBL] [Abstract][Full Text] [Related]
33. Nicotinamide reduces renal interstitial fibrosis by suppressing tubular injury and inflammation.
Zheng M; Cai J; Liu Z; Shu S; Wang Y; Tang C; Dong Z
J Cell Mol Med; 2019 Jun; 23(6):3995-4004. PubMed ID: 30993884
[TBL] [Abstract][Full Text] [Related]
34. Dermatan sulfate reduces monocyte chemoattractant protein 1 and TGF-β production, as well as macrophage recruitment and myofibroblast accumulation in mice with unilateral ureteral obstruction.
Belmiro CL; Gonçalves RG; Kozlowski EO; Werneck AF; Takyia CM; Leite M; Pavão MS
Braz J Med Biol Res; 2011 Jul; 44(7):624-33. PubMed ID: 21833458
[TBL] [Abstract][Full Text] [Related]
35. Ablation of Gadd45β ameliorates the inflammation and renal fibrosis caused by unilateral ureteral obstruction.
Moon SJ; Kim JH; Choi YK; Lee CH; Hwang JH
J Cell Mol Med; 2020 Aug; 24(15):8814-8825. PubMed ID: 32570293
[TBL] [Abstract][Full Text] [Related]
36. Specific Inhibitor of Smad3 (SIS3) Attenuates Fibrosis, Apoptosis, and Inflammation in Unilateral Ureteral Obstruction Kidneys by Inhibition of Transforming Growth Factor β (TGF-β)/Smad3 Signaling.
Ji X; Wang H; Wu Z; Zhong X; Zhu M; Zhang Y; Tan R; Liu Y; Li J; Wang L
Med Sci Monit; 2018 Mar; 24():1633-1641. PubMed ID: 29555895
[TBL] [Abstract][Full Text] [Related]
37. ATF6α downregulation of PPARα promotes lipotoxicity-induced tubulointerstitial fibrosis.
Jao TM; Nangaku M; Wu CH; Sugahara M; Saito H; Maekawa H; Ishimoto Y; Aoe M; Inoue T; Tanaka T; Staels B; Mori K; Inagi R
Kidney Int; 2019 Mar; 95(3):577-589. PubMed ID: 30639234
[TBL] [Abstract][Full Text] [Related]
38. Ribes diacanthum Pall (RDP) ameliorates UUO-induced renal fibrosis via both canonical and non-canonical TGF-β signaling pathways in mice.
Gu L; Wang Y; Yang G; Tilyek A; Zhang C; Li S; Yu B; Chai C; Cao Z
J Ethnopharmacol; 2019 Mar; 231():302-310. PubMed ID: 30342194
[TBL] [Abstract][Full Text] [Related]
39. Human umbilical cord-derived mesenchymal stem cells conditioned medium attenuate interstitial fibrosis and stimulate the repair of tubular epithelial cells in an irreversible model of unilateral ureteral obstruction.
Liu B; Ding FX; Liu Y; Xiong G; Lin T; He DW; Zhang YY; Zhang DY; Wei GH
Nephrology (Carlton); 2018 Aug; 23(8):728-736. PubMed ID: 28667820
[TBL] [Abstract][Full Text] [Related]
40. Gastrin, via activation of PPARα, protects the kidney against hypertensive injury.
Gu D; Fang D; Zhang M; Guo J; Ren H; Li X; Zhang Z; Yang D; Zou X; Liu Y; Wang WE; Wu G; Jose PA; Han Y; Zeng C
Clin Sci (Lond); 2021 Jan; 135(2):409-427. PubMed ID: 33458737
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
